Abstract
Body-mass index (BMI) is a well-known marker of adiposity across all ages. The genetic architecture of BMI has been thoroughly studied among adults. In contrast, there are a few genome-wide association studies (GWAS) on children. Further, GWAS on children have been performed almost exclusively in Europeans at single ages. We aimed to better understand the genetic architecture of BMI trajectory across ages and how BMI is affected by Native American genetic ancestry. We performed cross-sectional and longitudinal GWAS for BMI-related traits on 904 admixed Chilean children with mostly European and Mapuche Native American genetic ancestry. We focused on BMI and two traits that occur at the minimum of the childhood BMI growth trajectory, namely, age at adiposity rebound (Age-AR) and BMI at adiposity rebound (BMI-AR). We found several variants in the immune gene HLA-DQB3 that are strongly associated with BMI at ages 1.5-2.5 years old, but not at other ages. We also identified a variant in the sex-determining gene DMRT1 significantly associated with Age-AR (P = 9.8 × 10−9). Further, BMI was significantly higher in Mapuche than in European children at all ages between 5.5 and 16.5 years old, but not before. Finally, Age-AR was significantly lower (P = 0.013) by 1.64 years in the Mapuche children compared with Europeans.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Fondo Nacional de Ciencia y Tecnologĺa (FONDECYT) [1200146 to S.E., L.V. and E.B.; 1190346 to V.M.; 1150416 and 1150486 to JL.S., 1190801 to C.M. ]. S.E., T.N. and L.V. were additionally supported by the Instituto Milenio de Investigación Sobre los Fundamentos de los Datos (IMFD). S.E. conceived the project. S.E. and L.V. designed experiments. E.B., L.V., T.N., C.M., D.A. and V.L. analyzed the data. A.P. and V.M. collected phenotype data. S.E., JL. S. and JC. G. raised funds for the genotyping data. L.V., S.E., A.P, E.B. wrote the manuscript. All authors critically reviewed and accepted the final version.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Informed consents from participants were obtained from parents or guardians. Children agreed to participate when they turned 7 years old. This study was approved by the Scientific Ethics Committees of Instituto de Nutrición y Tecnologĺa en Alimentos (INTA) and Pontificia Universidad Católica de Chile.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We can provide summary data upon request.
